Acrotech Drug Patent Portfolio
Acrotech owns 1 orange book drug protected by 6 US patents Given below is the list of Acrotech's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7247316 | Compositions and methods for treating lymphoma | 25 Sep, 2020 | Expired |
| US6723338 | Compositions and methods for treating lymphoma | 31 Mar, 2020 | Expired |
| US7887836 | Compositions and methods for treating lymphoma | 31 Mar, 2020 | Expired |
| US5543152 | Sphingosomes for enhanced drug delivery | 20 Jun, 2014 | Expired |
| US5741516 | Sphingosomes for enhanced drug delivery | 20 Jun, 2014 | Expired |
| US5814335 | Sphingosomes for enhanced drug delivery | 20 Jun, 2014 | Expired |
Latest Legal Activities on Acrotech's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Acrotech.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 20 Mar, 2023 | US7887836 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Oct, 2022 | US7887836 |
| 11.5 yr surcharge- late pmt w/in 6 mo, Small Entity | 28 Jan, 2019 | US7247316 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 28 Jan, 2019 | US7247316 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Aug, 2018 | US7887836 |
| Notice of Final Determination- Ineligible | 31 Mar, 2015 | US7887836 |
|
Email Notification
Critical
| 12 Feb, 2015 | US7247316 |
| Filing Receipt - Corrected | 12 Feb, 2015 | US7247316 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 12 Feb, 2015 | US7247316 |
|
Correspondence Address Change
Critical
| 11 Feb, 2015 | US7247316 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 05 Feb, 2015 | US7247316 |
| Letter from FDA or Dept of Agriculture re PTE application | 31 Jan, 2014 | US7887836 |
| Initial letter Re: PTE Application to regulating agency | 19 Jun, 2013 | US7887836 |
| Patent Term Extension Application under 35 USC 156 Filed | 05 Oct, 2012 | US7887836 |
|
Case Docketed to Examiner in GAU
Critical
| 01 Mar, 2012 | US7247316 |
Acrotech's Family Patents
Acrotech Drug List
Given below is the complete list of Acrotech's drugs and the patents protecting them.
1. Marqibo Kit
Marqibo Kit is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7247316 | Compositions and methods for treating lymphoma |
25 Sep, 2020
(4 years ago)
| Expired |
| US6723338 | Compositions and methods for treating lymphoma |
31 Mar, 2020
(4 years ago)
| Expired |
| US7887836 | Compositions and methods for treating lymphoma |
31 Mar, 2020
(4 years ago)
| Expired |
| US5543152 | Sphingosomes for enhanced drug delivery |
20 Jun, 2014
(10 years ago)
| Expired |
| US5741516 | Sphingosomes for enhanced drug delivery |
20 Jun, 2014
(10 years ago)
| Expired |
| US5814335 | Sphingosomes for enhanced drug delivery |
20 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Marqibo Kit's drug page